National trends in use and costs of oral anticancer drugs in France: An 8-year population-based study.
Pauline Bosco-LevyPaul de BoissieuAmandine GouverneurPernelle NoizeMathieu MolimardAnnie Fourrier-RéglatJulien BezinPublished in: Pharmacoepidemiology and drug safety (2017)
With the development of new OAcDs, the TTs use reaches a wider population of patients but is responsible for increasing health expenditures.